Company profile · Heidelberg, Germany

German Cancer Research Center

Cancer Research, Translational Oncology, Prevention Science, and National Research Infrastructure · Large national oncology-research centre

National oncology-research flagship with large translational infrastructure, cancer platforms, and Heidelberg ecosystem gravity.

Lead
Prof. Dr. Michael Baumann (verified ↗)
Address
Im Neuenheimer Feld 280, 69120 Heidelberg, Germany (source ↗)
Compliance
GLP
Last reviewed
15 Mar 2026 (3mo ago)
Scale
Large national oncology-research centre
Capabilities
Cancer biology research · Translational oncology · Population and prevention science
Founded
1964
Headcount
1001-5000
LinkedIn
Company page (open ↗)
Site and address
Clinical profileSTATUS: VERIFIED MARCH 2026

Prof. Dr. Michael Baumann

Chairman and Scientific Director

Check official leadership source
Full addressIm Neuenheimer Feld 280, 69120 Heidelberg, Germany
Site coordinates49.414210, 8.671640
Review cycleMay 2026
Physical site source

Official DKFZ contact page listing Im Neuenheimer Feld 280, Heidelberg.

Open source
Operating profile

Large national oncology-research centre

Heidelberg, Germany. Cancer Research, Translational Oncology, Prevention Science, and National Research Infrastructure. Review completed on 15 Mar 2026.

2026 technical specializationCancer Research, Translational Oncology, Prevention Science, and National Research Infrastructure
Core capabilities
Cancer biology researchTranslational oncologyPopulation and prevention scienceNational technology and data platforms
Governance

Helmholtz and German federal oncology-research governance framework

Good scientific practice framework, National oncology research governance

Editorial note

Cancer Research, Translational Oncology, Prevention Science, and National Research Infrastructure

National oncology-research flagship with large translational infrastructure, cancer platforms, and Heidelberg ecosystem gravity.

Editorial note

DKFZ is a heavyweight Heidelberg anchor with formal scientific leadership, large-scale oncology infrastructure, and deep translational relevance for the cluster.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026Last reviewed: 15 March 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

Cancer biology research
Translational oncology
Population and prevention science
National technology and data platforms
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidenceDKFZ official organization-and-management page confirming Michael Baumann as Chairman and Scientific Director.Source origin: dkfz.deOpen source
Supporting evidenceDKFZ official profile page describing institutional scale and research programmes.Source origin: dkfz.deOpen source
Physical-site evidenceOfficial DKFZ contact page listing Im Neuenheimer Feld 280, Heidelberg.Source origin: dkfz.deOpen source
Infrastructure

Declared infrastructure

Cancer research laboratories
National core facilities
Translational oncology platforms
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
REVIEW IN PROGRESS 2026
GLP
VERIFIED ACTIVE 2026
ISO-13485
REVIEW IN PROGRESS 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

15 Mar 2026: Executive identity confirmed via official management disclosure.
15 Mar 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is German Cancer Research Center located?
German Cancer Research Center operates from Im Neuenheimer Feld 280, 69120 Heidelberg, Germany, Heidelberg, Germany.
Who runs German Cancer Research Center?
German Cancer Research Center is led by Prof. Dr. Michael Baumann, Chairman and Scientific Director. Verified 15 Mar 2026.
What does German Cancer Research Center do?
National oncology-research flagship with large translational infrastructure, cancer platforms, and Heidelberg ecosystem gravity. Core capabilities: Cancer biology research, Translational oncology, Population and prevention science, National technology and data platforms.
Editorial context

Related technical briefs

Briefs that name Heidelberg as a covered market or city.